Bymetric
UK company intelligence
Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Cell and Gene Therapy Catapult

UK company 10016023, incorporated on 19 February 2016.

Advancing cell and gene therapies through powerful collaborations - Cell and Gene Therapy

Cell and Gene Therapy Catapult is a UK company with status active founded in 2016 based in London.

Company number
10016023
Incorporated
19 Feb 2016
Companies House status
Active

Company identity

Founded / incorporated
19 February 2016

Company number 10016023

Verify at Companies House
Legal name
CELL AND GENE THERAPY CATAPULT
Company type
PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION
Region
London
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION
Cell and Gene Therapy Catapult
CRN 10016023
2
Direct and ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC
Cell Therapy Catapult Limited
CRN 07964711

Latest accounts

Financial period: 1 Mar 2024 to 28 Feb 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
Unknown

Company events

Reference milestones and recent Companies House filing stream events.

1 event
19 Feb
2016

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2017
Funded years
2017, 2018, 2021
Age at first award
1 years

Projects

2021 Collaborative R&D Lead participant

ATTC Coordination

1 Apr 2021 to 31 Mar 2022

Awarded
£302,929
Total cost £302,929
2021 Centres

Patent-reported outcomes assessment to support accelerated access to advanced cell and gene therapies: PROmics

1 Apr 2021 to 31 Mar 2022

Awarded
£13,887
Total cost £13,887
2018 Centres Lead participant

ISCF Funding for Advanced Therapy Manufacturing Apprenticeships

1 Jul 2018 to 30 Apr 2021

Awarded
£1,499,198
Total cost £1,499,198

Awaiting Public Project Summary

2018 Centres Lead participant

ATTC Coordination

1 Jun 2018 to 31 Mar 2022

Awarded
£1,706,975
Total cost £1,706,975

Awaiting Public Project Summary

2017 Centres Lead participant

ISCF Funding for Phase 2 of the C&GT Catapult Manufacturing Centre

1 Aug 2017 to 31 Oct 2019

Awarded
£10,000,000
Total cost £10,000,000

Awaiting Public Project Summary

Product types

Centres Collaborative R&D